Product
Supplier
Encyclopedia
Inquiry
Home > Active Pharmaceutical Ingredients > Other Chemical Drugs > tesofensine for Sale > Factory supply Tesofensine powder CAS 195875-84-4
Factory supply Tesofensine powder CAS 195875-84-4 buy - large image1
Factory supply Tesofensine powder CAS 195875-84-4 buy - image1

Factory supply Tesofensine powder CAS 195875-84-4

GMP FDA 81 Inquiries

Unit Price: Get Latest Price
CAS No.:

195875-84-4

Grade:

Pharmaceutical Grade

Content:

99%

Port:

shanghai/shenzhen

Brand:

DAZE

Packaging:

25kg/drum, 180kg/drum

Sample Available:

Yes

Price valid (until):

2024-08-07

Company Type:
Trader
Location:
China
Payment Terms:
TT against copy of documents,D/P,D/A,TT against B/L draft before shipment,100% TT in advance
Average Lead Time:
10 days
Qualification:
Main Products:

pharmaceutial intermediate

  • Product Description

  • Seller Information

  • Inquiry History

  • Description


       Product Detail  



    Shop Factory supply Tesofensine powder CAS 195875-84-4-Detailed Image 1

    Tesofensine is a dopamine, serotonin, and noradrenaline (triple) reuptake inhibitor originally developed by NeuroSearch for the treatment of Alzheimer's disease and Parkinson's disease. Development of the compound for these neurological indications was unsuccessful but significant weight loss was reported during the clinical trials in Parkinson's disease. Hence, tesofensine is now being developed by NeuroSearch for the treatment of obesity and type 2 diabetes.

    Tesofensine, is a serotonin–noradrenaline–dopamine reuptake inhibitor from the phenyltropane family of drugs, which is currently in clinical development for the treatment of obesity.


      Package


    Shop Factory supply Tesofensine powder CAS 195875-84-4-Detailed Image 2


       Company


    Shop Factory SARMS SR9011 powder-Detailed Image 2


       Shipping


    Shop Factory SARMS SR9011 powder-Detailed Image 3

    ECHEMI Editorial Reference
    Tesofensine ((1R, 2R, 3S, 5S)-3-(3, 4-dichlorophenyl)-2-(ethoxymethyl)-8-methyl-8-azabicyclo[3.2.1]octane)) is an inhibitor of neuronal reuptake of dopamine, noradrenaline, and serotonin. Tesofensine was developed for the treatment of Alzheimer's and Parkinson's disease but lacked efficacy. Meta-analysis revealed that tesofensine (0.125–1.0 mg, once daily; oral) produced dose-dependent weight loss, and 32% of obese patients had ≥ 5% weight loss following 14 wk of treatment. Weight loss was accompanied by hypophagia, suggesting an appetite suppressant action[2].
    Tesofensine is a dopamine, serotonin, and noradrenaline (triple) reuptake inhibitor originally developed by NeuroSearch for the treatment of Alzheimer's disease and Parkinson's disease. Development of the compound for these neurological indications was unsuccessful but significant weight loss was reported during the clinical trials in Parkinson's disease. Hence, tesofensine is now being developed by NeuroSearch for the treatment of obesity and type 2 diabetes[1].

    Certificates

    Basic Info
    Product Name:

    tesofensine

    Other Name:

    (1S,3S,4R,5R)-3-(3,4-dichlorophenyl)-4-(ethoxymethyl)-8-methyl-8-azabicyclo[3.2.1]octane;(1R,2R,3S,5S)-3-(3,4-Dichlorophenyl)-2-(ethoxymethyl)-8-methyl-8-azabicyclo[3.2.1]octane;Tesofensine-13C-d3;8-Azabicyclo[3.2.1]octane, 3-(3,4-dichlorophenyl)-2-(ethoxymethyl)-8-methyl-, (1R,2R,3S,5S)-;Tesofensine 500mcg Tablets;Tesofensine 0.5mg Tablets

    CAS No.:

    195875-84-4

    Molecular Formula:

    C17H23Cl2NO

    InChIKeys:

    VCVWXKKWDOJNIT-ZOMKSWQUSA-N

    Molecular Weight:

    328.28

    Exact Mass:

    328.28

    UNII:

    BLH9UKX9V1

    Color/Form:

    White to off-white

    Categories:

    Other Chemical Drugs

    Characteristics
    Density:

    1.161±0.06 g/cm3(Predicted)

    Boiling Point:

    396.6±42.0 °C(Predicted)

    PKA:

    10.46±0.60(Predicted)

    Critical Temperature & Pressure:

    Store at -20°C

  • Seller Information
    Business Type:

    Trader

    Main Products:

    pharmaceutial intermediate

    Location:

    No.26, dongqing road, gaoxin district, zhengzhou, P.R.China

    Payment Terms:

    TT against copy of documents,D/P,D/A,TT against B/L draft before shipment,100% TT in advance

    Average lead Time:

    10 days

    Total Annual Revenue:

    $2.5 million-$5 million

    Total Employees:

    51-100

    Year of Establishment:

    2023

  • Inquiry History
    81 Inquiries
    Country Product Purchase Quantity Date Posted
    United Kingdom

    CAS: 195875-84-4

    10 G Oct 25, 2025
    Indonesia

    High quality Tesofensine 500mcg cas 195875-84-4 100pcs/bottle

    4  Apr 18, 2025
    United States

    High Purity Tesofensine Powder 99% White Powder CAS 195875-84-4 EGC-Tesofensine Powder

    1 KG Oct 27, 2023
    Spain

    tesofensine

    250 MG Oct 10, 2026
    Australia

    tesofensine

    10 G Oct 9, 2026
    United States

    Tesofensine

    1 G May 30, 2026
    United States

    Tesofensine

    10 G May 27, 2026
    United Kingdom

    Tesofensine

    1 G May 16, 2026
    United Kingdom

    Tesofensine

    1 G May 10, 2026
    United Kingdom

    Tesofensine

    10 G Apr 20, 2026
    United Kingdom

    Tesofensine

    100 PCS Apr 11, 2026
    United States

    Tesofensine

    1 KG Mar 8, 2026
    India

    Tesofensine

    10 MG Feb 22, 2026
    United States

    Tesofensine

    20 G Feb 14, 2026
    Thailand

    High purity 99% Tesofensine white powder

    500 MT Dec 12, 2025
    France

    Tesofensine

    200  Nov 1, 2025
    United States

    Tesofensine

    5 G Oct 8, 2025
    Switzerland

    tesofensine

    1000 MT Sep 4, 2025
    United States

    tesofensine

    1 KG Aug 4, 2025
    United States

    Tesofensine

    10 G Jul 5, 2025
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.